Warning letter
Respironics California Inc: warning letter of Nov 17, 2014
FDA warning letter 432772 · Los Angeles District Office
Key facts
| Reference number | 432772 |
|---|---|
| Company | Respironics California Inc |
| Subject | Medical Device Reporting/Misbranded |
| Issue date | Nov 17, 2014 |
| Posted date | Jan 13, 2015 |
| Issuing office | Los Angeles District Office |
| Product type | Devices |
| CFR sections cited | 803, 803.3, 803.56, 803.50(a)(2), 803.50(a), 803.50(b)(3) |
| Inspection city | Carlsbad |
| Inspection ZIP | 92011-1517 |
| Inspection start date | Apr 14, 2014 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- ADC Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: